A short clip looks back at Canadian scientist Daniel Drucker and his early research at Harvard that helped lay the groundwork for today's GLP-1 medicines.
Recap by typeshit. Video by @begiantca on TikTok.
A Facebook post says US researchers found pancreatic cells producing GLP-1 on their own. It frames this as a possible built-in appetite and sugar control system, without naming the study.
Researchers are studying whether GLP-1 drugs, which act on mood, appetite and reward pathways, could help with depression, addiction and binge eating.
A retrospective cohort checks whether retinal disease started or worsened more in established users than in people never on either drug, plus a regional NAION review.
24:34
An animated explainer walking through what semaglutide does in the body, from appetite signals in the brain to digestion and blood sugar control.
Two in vitro studies backed by the Spanish supplier report more GLP-1, CCK and short chain fatty acid output. Pharmactive notes no human trials yet.
Cost, coverage gaps and side effects often push people off GLP-1s, and News-Medical covers research on whether follow-up support helps keep weight from returning.
Loading…